AGP Executive Report
Last update: 5 hours agoOligonucleotide Breakthroughs: Oligonucleotide therapies are expanding fast, with more than 20 approved and 700+ in development, and conjugation chemistry emerging as a key way to improve stability, delivery, and targeting. EU Disaster Response: The EU is mobilizing rescue teams and medical staff to support earthquake-hit Venezuela, including firefighters, rescue dogs, and satellite support. Diabetes Tech Rollout: Modular Medical says its Pivot tubeless insulin patch pump is now shipping to endocrinology practices for training, with phased expansion planned through late 2026. Drug Pricing Tensions: The Trump administration is probing Germany over “persistent underpayment” for U.S. medicines, escalating pressure on pricing and trade terms. Health Data Privacy: England’s NHS is investigating about 40 staff who accessed a boy’s medical records after a crocodile attack, with the trust referring the matter to the information watchdog. EMA Updates: The CHMP issued a mix of positive opinions and one major setback—recommending changes for multiple medicines (including Orladeyo, Rinvoq, and new biosimilars) while recommending revoking Tavneos after concerns about benefit-risk balance. Fraud Spotlight: A Glendale doctor was convicted for allegedly billing Medicare $45M for Botox claims that were never performed or justified.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
